GET A PIECE OF REUZEIT
Circular Economic Surplus Asset Management
$194,184.88 Raised
Reasons to Invest
- REUZEit generated $6.6 Million in revenue in our last fiscal year and we are ready to scale. REUZEit provides Surplus Asset Management for ThermoFisher Scientific, Gilead Pharmaceuticals, BioMarin Pharmaceutical, Kita Pharma, Abbott Laboratories, and more.
The global laboratory supplies market was estimated at $32.6 billion in 2021, growing at a CAGR of 7.5%. (source)
The REUZEit platform is already used by some of the largest life sciences companies in the world. REUZEit franchises are a copy-and-paste scale plan to serve the thousands of international locations operated by our multi-national clients. Franchises bring in new clients in new regions too.* REUZEit started two franchises* already, in the Netherlands (in 2019) and the UK (in 2020), and we are ready to scale.
*Franchises are owned by 3rd parties, not owned by REUZEit Inc
overview
Lab & pharmaceutical equipment from our circular, economic platform
At REUZEit, we manage surplus equipment in life science and pharma companies, enabling them to “reuze” their own equipment through our net positive, sustainable service and technology.
With boots-on-the-ground, we pick up excess equipment from virtually anywhere, making it easy for companies to recondition and redeploy equipment or sell it for capital recovery. By selling our clients’ excess equipment on consignment, our clients earn more money than all our provided services cost combined, making REUZEit a financially sustainable vendor, and our clients are motivated to expand our program within their organization with no net cost, according to our internal research.
By blending circular economics and surplus assets together, we believe we bring value to the biotech and pharmaceutical industry, the environment, and shareholders alike.
The Problem & our solution
Instead of creating waste, we provide total life-cycle solutions for all surplus capital assets
We think manufacturers tend to focus on ‘next generation’ equipment instead of recovering surplus assets. In our view, this may lead to billions in valuable assets depreciating in off-site storage units, or worse, simply sent to a landfill.
We are here to put these assets back to work, profitably and sustainably. That's why the REUZEit platform captures and delivers access to its upstream and downstream customers in the life science and pharmaceutical industries. This allows for high-value resell and confident redeployment of surplus equipment.
Our turn-key Surplus Asset Management system provides pickups, storage, reconditioning, redeployment, capital recovery and much more. On top of that, our integrated software provides clients with transparent reporting and sustainability KPIs (source).
Our published white paper shows our clients that our SAM program is 99.7% more effective at reducing GreenHouse Gas equivalents (GHG or C02 kg eq/prod ) by reusing instead of replacing equipment they already own. (source)
The cost of the program is paid for the equipment REUZEit recovers and sells for our clients.
REUZEit earns $1 per year for every $2.50 of value in our warehouses.
Growth Strategies:
- North America- REUZEit is currently expanding its Business Development team to service existing clients and solicit new ones; earlier this year, REUZEit secured a global contract with Gilead Pharmaceuticals and we have more fortune 500 clients in our pipeline.
- Other Sectors- REUZEit will leverage its platform and expertise in surplus asset management to enter new sectors like Health Care and Consumer Goods, using our franchise model.
Franchises and Scalability: (A franchise is a branch owned by 3rd party, not REUZEit Inc.)
- EMEA- in 2019, REUZEit has already established its own franchise warehouse and operations in the Netherlands to service the needs of its global clients in the EMEA.
- UK - in 2020, REUZEit established a franchise in the UK
- Other Regions - REUZEit continues to develop the franchise model for regional partners in markets where it may not want to set up its own operations.
The Market & our traction
We think there is a huge opportunity to get the entire world in a reuse economy
The global laboratory supplies market was estimated at $32.6 billion in 2021, growing at a CAGR of 7.5% (source). With 6.5% of the market for lab equipment being reused, REUZEit estimates the current addressable market of used lab equipment to be $1.3 billion dollars globally (source).
Plus, we don’t think our competition has boots on the ground as we do. Based on our recent traction, it seems that REUZEit users know that too.
3 of our clients under contract are on the list of the world’s 15 largest Biotech companies
(source)
- We added Gilead Pharmaceuticals to our platform of clients in Q1 2022.
- Our current total Assets Under Management (AUM)is 16 million in the US, as of July 2022.
- We have managed over $70 million in equipment in the USA from 2017 through 2022.
- We received a $1.4 million SBA loan and started development on our next software and marketplace, expected to go live at the end of this year.
- Harold Krikke, PhD, a thought leader in Circular Economics, recently published a paper based on our real-world data using CE-SAM with international Life-Science companies over the past 7 years.
Why Invest
We believe this is a rare opportunity to invest in profitability, and in the environment
We think companies using REUZEit may gain a competitive advantage in organic productivity, supply chain relief, and more. That’s because REUZEit acquires equipment at near zero cost, selling them at attractive prices by resetting market rates, all while reducing global greenhouse gas emissions, in our view.
Continuing this mission to meet new demand, we will use funding to build the team, increase brand awareness, expand IT, and operational infrastructure necessary to achieve our growth objectives. Now is the time to get in on the ground floor of blending circular economics and surplus assets together - invest today!
ABOUT
HEADQUARTERS
28381 Vincent Moraga Dr.
Temecula, CA 92590
WEBSITE
View Site
REUZEit (pronounced “Re Use It” ) started in 2010 and incorporated in 2014, serving large organizations in the Life Science and Pharmaceutical Industries. REUZEit is currently in the market with our asset lifecycle service, and we are building what we believe is one of the world's largest B2B circular economic platforms to manage technology's most valuable scientific and pharmaceutical equipment.
TEAM
Justin Andrews
Chief Executive Officer & Co-Founder
Ryan Andrews
Chief Innovation Officer & Co-Founder
Casi Mayo
Chief Operations Officer
Dave Ward
Chief Strategy Officer
Jonah Shell
Chief Sustainability Officer
Mike Kish
Director, Global Business Development and Client Services
Steve Balmer
Sales Director
Nick Velis
Senior Program Manager
TERMS
REUZEit
Overview
PRICE PER SHARE
$0.80
DEADLINE
Feb 16, 2023
VALUATION
$40M
FUNDING GOAL
$10k - $1.24M
Breakdown
MIN INVESTMENT
$249.60
MAX INVESTMENT
$1,235,000
MIN NUMBER OF SHARES OFFERED
12,500
MAX NUMBER OF SHARES OFFERED
1,543,750
OFFERING TYPE
Equity
ASSET TYPE
Common Stock
SHARES OFFERED
Common Stock
Maximum Number of Shares Offered subject to adjustment for bonus shares
Voting Rights of Securities Sold in this Offering
Voting Proxy. Each Subscriber shall appoint the Chief Executive Officer of the Company (the “CEO”), or his or her successor, as the Subscriber’s true and lawful proxy and attorney, with the power to act alone and with full power of substitution, to, consistent with this instrument and on behalf of the Subscriber, (i) vote all Securities, (ii) give and receive notices and communications, (iii) execute any instrument or document that the CEO determines is necessary or appropriate in the exercise of its authority under this instrument, and (iv) take all actions necessary or appropriate in the judgment of the CEO for the accomplishment of the foregoing. The proxy and power granted by the Subscriber pursuant to this Section are coupled with an interest. Such proxy and power will be irrevocable. The proxy and power, so long as the Subscriber is an individual, will survive the death, incompetency and disability of the Subscriber and, so long as the Subscriber is an entity, will survive the merger or reorganization of the Subscriber or any other entity holding the Securities. However, the Proxy will terminate upon the closing of a firm-commitment underwritten public offering pursuant to an effective registration statement under the Securities Act of 1933 covering the offer and sale of Common Stock or the effectiveness of a registration statement under the Securities Exchange Act of 1934 covering the Common Stock
*Maximum number of shares offered subject to adjustment for bonus shares. See Bonus info below.
Investment Incentives & Bonuses*
Loyalty Bonus | 10% Bonus Shares
Members of REUZEIt’s Loyalty Bonus are eligible for additional bonus shares.
Time-Based:
Friends and Family Early Birds
Invest within the first 5 days and receive 20% bonus shares.
Super Early Bird Bonus
Invest within the first week and receive 10% bonus shares.
Early Bird Bonus
Invest within the first two weeks and receive 5% bonus shares.
Amount-Based:
$500+ | Tier 1
Invest $500+ and receive access to private investor newsletter.
$1,000+ | Tier 2
Invest $1,000+ and receive access to private investor newsletter + 5% bonus shares.
$2,500+ | Tier 3
Invest $2,500+ and receive access to private investor newsletter + 5% bonus shares + Invitation to software launch party.
$10,000+ | Tier 4
Invest $10,000+ and receive access to private investor newsletter + 10% bonus shares + Invitation to software launch party.
$25,000+ | Tier 5
Invest $25,000+ and receive Access to private investor newsletter + 15% bonus shares + Invitation to software launch party.
$50,000+ | Tier 6
Invest $50,000+ and receive Access to private investor newsletter + 20% bonus shares + Invitation to software launch party + Tour of Headquarters with one of the founders + Temecula wine country experience, includes one night stay.
*In order to receive perks from an investment, one must submit a single investment in the same offering that meets the minimum perk requirement. Bonus shares from perks will not be granted if an investor submits multiple investments that, when combined, meet the perk requirement. All perks occur when the offering is completed.
The 10% StartEngine Owners' Bonus
REUZEit will offer 10% additional bonus shares for all investments that are committed by investors that are eligible for the StartEngine Crowdfunding Inc. OWNer's bonus.
This means eligible StartEngine shareholders will receive a 10% bonus for any shares they purchase in this offering. For example, if you buy 100 shares of Common Stock at $0.80 / share, you will receive 110 shares of Common Stock, meaning you'll own 110 shares for $80. Fractional shares will not be distributed and share bonuses will be determined by rounding down to the nearest whole share.
This 10% Bonus is only valid during the investors' eligibility period. Investors eligible for this bonus will also have priority if they are on a waitlist to invest and the company surpasses its maximum funding goal. They will have the first opportunity to invest should room in the offering become available if prior investments are canceled or fail.
Investors will receive the highest single bonus they are eligible for among the bonuses based on the amount invested and time of offering elapsed (if any). Eligible investors will also receive the Owner’s Bonus in addition to the aforementioned bonus.
Irregular Use of Proceeds
The Company will not incur any irregular use of proceeds.
PRESS
Innovation Quarter
Landfill is no place for excess high-value equipment, according to REUZEit, who facilitates redistribution: Over 3,5 million kg of equipment was saved from the landfill by just one REUZEit client over the last few years. Instead, the equipment was redeployed, resold or recycled, facilitated by the R
ALL UPDATES
Stack Owner's Bonus & Rewards!
Members get an extra 10% shares in addition to rewards below!
REWARDS
JOIN THE DISCUSSION
0/2500
Carolyn Miller
9 months ago
The company's bottom line took a drastic turn for the worse in the most recent year mostly attributed to increased payroll costs. Has the addition of the sales and marketing personnel resulted in an increase in revenue year over year from 2021 to 2022? That cost is a huge drain on cashflow.
1
1
Orion Torcellini
9 months ago
Ahh, ok if the note is not compounding but just running interest on the balance its not as egregious, I apologize if it seemed I was attacking you but I think its best to ask these questions early and your answers were more than satisfactory. Happy to be investing
1
0
Michael Brody
10 months ago
Maybe I missed it- but you mention gross revenues; and cost of business. What are your actual after expenses/after taxes profits over each of last two years?
1
0
Orion Torcellini
10 months ago
So what does that mean exactly? If you do not plan to repay the loan “anytime soon”, then it will continue to grow with interest. Not Compounding monthly is great, but it is still compounding annually and “not anytime soon” could be many years away. There is nothing wrong with recouping your initial cash injection, but to set it at 15% annually is certainly one i have not seen before (7.5% highest seen before this). I am just curious what the benefit to the company would be to sit on those promissory notes, I know the benefit to you is $22,500 a year (for the first year) and nearly $450,000 in total interest should the loans be allowed to mature to 2032 and 2031, but I’d like to know why you believe immediate repayment to not be a net positive for the company. There are several other loans made by you and what i assume to be your brother with no interest, so I am curious.
I am curious on your thought process and eagerly await a reply!
1
0
Orion Torcellini
10 months ago
Do you plan to payoff in full both promissory notes held by the CEO? $156,000 at 15% annually will become a net drag on the company for the CEOs benefit very quickly. Please let me know
1
0
Felix Vayssieres
10 months ago
Hi, I love your mission. Why don't these life science and pharmaceutical companies already reuse and resell their equipment by themselves? What makes it challenging enough for them to do that they would rather hire you instead? Thanks
1
2
Richard Koch
10 months ago
What is the method of payment for the company when a piece of property changes hands? How does a franchisee agreement work (from the 30,000 foot level?)
1
1
ANTHONY BARBATO
10 months ago
Justin,
I am glad to see that you are doing well.
At this time all my investment is tied up in my property at Fallbrook.
Thank you for reaching out to me.
Your mom Rene has told me how great you are doing.
I look forward to catching up with you in the future.
If ever you are in town visiting your mom, please stop by my property.
I think that you will like what I am doing.
Monday my solar system will be delivered and the well is complete. Soon the irrigation lines will be going in.
By this spring I hope to have many avocados planted.
I will officially become a farmer.
All off grid!
Feel free to give me a call anytime.
And thanks again.
Uncle Tony.
909-645-1340
3
0
HOW INVESTING WORKS
Cancel anytime before 48 hours before a rolling close or the offering end date.
WHY STARTENGINE?
REWARDS
We want you to succeed and get the most out of your money by offering rewards and memberships!
SECURE
Your info is your info. We take pride in keeping it that way!
DIVERSE INVESTMENTS
Invest in over 200 start-ups and collectibles!
With Regulation A+, a non-accredited investor can only invest a maximum of 10% of their annual income or 10% of their net worth per year, whichever is greater. There are no restrictions for accredited investors.
With Regulation Crowdfunding, non-accredited investors with an annual income or net worth less than $124,000, are limited to invest a maximum of 5% of the greater of those two amounts. For those with an annual income and net worth greater than $124,000, he/she is limited to investing 10% of the greater of the two amounts.
At the close of an offering, all investors whose funds have “cleared” by this time will be included in the disbursement. At this time, each investor will receive an email from StartEngine with their Countersigned Subscription Agreement, which will serve as their proof of purchase moving forward.
Please keep in mind that a company can conduct a series of “closes” or withdrawals of funds throughout the duration of the campaign. If you are included in that withdrawal period, you will be emailed your countersigned subscription agreement and proof of purchase immediately following that withdrawal.
StartEngine assists companies in raising capital, and once the offering is closed, we are no longer involved with whether the company chooses to list shares on a secondary market, or what occurs thereafter. Therefore, StartEngine has no control or insight into your investment after the close of the live offering. In addition, we are not permitted to provide financial advice. You may want to contact a financial professional to discuss possible investment outcomes.
For Regulation Crowdfunding, investors are able to cancel their investment at any point throughout the campaign up until 48 hours before the closing of the offering. Note: If the company does a rolling close, they will post an update to their current investors, giving them the opportunity to cancel during this timeframe. If you do not cancel within this 5-day timeframe, your funds will be invested in the company, and you will no longer be able to cancel the investment. If your funds show as ‘Invested’ on your account dashboard, your investment can no longer be canceled.
For Regulation A+, StartEngine allows for a four-hour cancelation period. Once the four-hour window has passed, it is up to each company to set their own cancelation policy. You may find the company’s cancelation policy in the company’s offering circular.
Once your investment is canceled, there is a 10-day clearing period (from the date your investment was submitted). After your funds have cleared the bank, you will receive your refund within 10 business days.
Refunds that are made through ACH payments can take up to 10 business days to clear. Unfortunately, we are at the mercy of the bank, but we will do everything we can to get you your refund as soon as possible. However, every investment needs to go through the clearing process in order to get sent back to the account associated with the investment.
Both Title III (Regulation Crowdfunding) and Title IV (Reg A+) help entrepreneurs crowdfund capital investments from unaccredited and accredited investors. The differences between these regulations are related to the investor limitations, the differing amounts of money companies are permitted to raise, and differing disclosure and filing requirements. To learn more about Regulation Crowdfunding, click here, and for Regulation A+, click here.
Aron Roberts
7 months ago
1
0